Roche Holding AG (RHHBY) This autumn 2024 Earnings Name Transcript
Roche Holding AG (OTCQX:RHHBY) This autumn 2024 Earnings Convention Name January 30, 2025 8:00 AM ET
Firm Members
Thomas Schinecker – CEO
Alan Hippe – Chief Monetary & Info Officer
Teresa Graham – CEO, Roche Prescription drugs
Matt Sause – CEO, Roche Diagnostics
Bruno Eschli – Head, IR
Convention Name Members
Richard Vosser – JPMorgan
Emily Subject – Barclays
Sachin Jain – Financial institution of America
Matthew Weston – UBS
Simon Baker – Redburn
James Quigley – Goldman Sachs
Richard Parkes – BNP
Rajesh Kumar – HSBC
Justin Smith – Bernstein
Benjamin Jackson – Jefferies
Operator
[Starts Abruptly] In case you notice that the webinar is being recorded. I’d like to tell you that each one contributors are in listen-only mode, through the name. After the presentation, there will likely be a question-and-answer session. [Operator Instructions] One final comment, if you want to observe the offered slides in your finish as effectively, please be happy to go to roche.com/buyers to obtain the presentation.
Right now, it is my pleasure to introduce you to Thomas Schinecker, CEO of Roche Group. Mr. Schinecker, the stage is yours.
Thomas Schinecker
Thanks very a lot, and whats up to everybody, wherever on the earth you might be. I am actually excited to share with you the outcomes of 2024 for the Roche Group, as a result of I consider they’ve been — this yr has actually been a superb yr for us.
So let us take a look at the efficiency. So general, Group gross sales was at 7%. The bottom enterprise, which means excluding COVID-19, grew even with spectacular 9%, pharma 9%, and diagnostics 8%. We noticed the final and ultimate influence of COVID-19 gross sales in — discount in 2024, so there is no such thing as a extra influence going ahead. The ultimate influence was CHF1.1 billion, so precisely according to the steerage that we gave at first of the yr. The LOE influence was CHF1 billion. So barely higher than the steerage we
